REFRACTORY MULTIPLE SCLEROSIS

Clinical trials for REFRACTORY MULTIPLE SCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MULTIPLE SCLEROSIS trials appear

Sign up with your email to follow new studies for REFRACTORY MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Experimental CAR-T therapy targets Hard-to-Treat MS in small safety trial

Disease control Not yet recruiting

This early-stage study tests a new treatment called S103 (BCMA-CAR T cells) for people with progressive or hard-to-treat multiple sclerosis (MS). The main goal is to check if the treatment is safe and to find the right dose. Only 9 adults will take part, and the study is not yet …

Matched conditions: REFRACTORY MULTIPLE SCLEROSIS

Phase: PHASE1 • Sponsor: Xijing Hospital • Aim: Disease control

Last updated May 22, 2026 13:55 UTC

REFRACTORY MULTIPLE SCLEROSIS

Get alerted when new REFRACTORY MULTIPLE SCLEROSIS trials appear

Experimental CAR-T therapy targets Hard-to-Treat MS in small safety trial